Science
CME credits: 0.25 Valid until: 21-09-2021 Claim your CME credit at https://reachmd.com/programs/cme/keeping-pace-womens-cancer-focus-endometrial-carcinoma/11839/ There remains a critical unmet need for effective therapies following the recurrence of endometrial cancer. In this activity, Drs. Linda Duska and Richard Penson assess the role of immunotherapy and targeted therapies in managing advanced endometrial cancers, as well as the importance of evaluating the microsatellite and mismatch repair biomarker status of recurrent and metastatic endometrial cancer.